johnson & johnson - Search News

Johnson & Johnson Q4 Profit Decreases

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.

AOL · 8h

Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share.

Business Insider · 12h

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Johnson & Johnson (JNJ) announced a profit for fourth quarter that decreased from last year but beat the Street estimates. The

Ben Johnson introduced

USA Today · 7h

Ben Johnson introduced as Bears head coach: 'I wanted to stay in this division'

Ben Johnson expressed gratitude for his time with the Detroit Lions head coach, calling Dan Campbell a "friend" and "mentor" as he takes over Bears

NBC Sports on MSN · 6h

Ben Johnson takes dig at Packers coach Matt LaFleur

Ben Johnson had his choice of several jobs. He chose the Bears. Not only do they have a quarterback to build around, but Johnson also noted they are in a division with which he is familiar. Johnson spent six seasons in the NFC North as an assistant under Dan Campbell.

The Washington Post · 1d

With Ben Johnson on the move to Chicago, 5 head coaching vacancies remain

Ben Johnson made a quick decision. Aaron Glenn could be next. With Johnson heading to Chicago and Mike Vrabel already in New England, five head coaching vacancies remain. The Jets, Saints, Jaguars, Raiders and Cowboys are still in the hunt.

1don MSN

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

11h

Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond

Says starting 2025 from a position of strength. Says invested ~$50B in R&D and M&A in 2024. Says continues to invest in R&D at ...

MassDevice12h

Johnson & Johnson MedTech sales grow 6.2% in 2025, driven by EP, Abiomed

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

8hon MSN

Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance

Johnson & Johnson’s stock dropped more than 3% Wednesday after the medical-technology and drug company beat estimates for the fourth quarter but as lower sales guidance for the year stoked fears of ...

10h

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

12h

J&J Tops Q4 Adjusted Earnings Estimates, But 2025 Sales Outlook Falls Short

Johnson & Johnson posted its fourth-quarter earnings report Wednesday morning, with adjusted profits beating expectations ...

19h

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Johnson & Johnson has secured FDA approval for expanded use of its Spravato nasal spray, now cleared as a standalone ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Johnson & Johnson Q4 Profit Decreases

Ben Johnson introduced

Related topics